SpyGlass Pharma, Inc. Common Stock (SGP) Financials
SGP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 258.4 million | 8.3 million |
| Dec. 31, 2025 | 115.9 million | 214.7 million |
| Sept. 30, 2025 | 127.0 million | 214.2 million |
| March 31, 2025 | ? | ? |
SGP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -14.2 million | 1.7 million |
| Dec. 31, 2025 | -9.8 million | 922246 |
| Sept. 30, 2025 | ? | ? |
| March 31, 2025 | -8.4 million | 345000 |
SGP Net Income
No data available :(
SGP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 251.0 million | - | 1.6 million |
| Dec. 31, 2025 | 107.4 million | - | 1.6 million |
| Sept. 30, 2025 | 118.0 million | - | 3.6 million |
| March 31, 2025 | - | - | - |
SGP Shares Outstanding
SGP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 676000 | 8.2 million | 6.9 million | - |
| Dec. 31, 2025 | 420492 | 7.7 million | 5.9 million | - |
| Sept. 30, 2025 | - | - | - | - |
| March 31, 2025 | 164000 | 6.1 million | 1.4 million | - |
SGP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 318000 |
| Dec. 31, 2025 | - | 216726 |
| Sept. 30, 2025 | - | - |
| March 31, 2025 | - | - |
SGP
Price: $18.21
52 week price:
Earnings Per Share: -1.34 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 616.5 million